Market research
RWLK Rewalk Robotics Ltd
NASDAQ USD Healthcare
Latest close
As of 05 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 62M
- P/E ratio
- Not available
- Analyst target
- 3
- Dividend yield
- Not available
- Beta
- 2.31
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- IL0011331076
- Market cap
- 62M
- P/E ratio
- Not available
- Analyst target
- 3
- Dividend yield
- Not available
- Beta
- 2.31
About
About Rewalk Robotics Ltd
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Research context
Rewalk Robotics Ltd appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the RWLK discussion.
5 years, 6 months ago
ReWalk Robotics Ltd is currently in a long term downtrend where the price is trading 18.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.1.
ReWalk Robotics Ltd's total revenue rose by 3.1% to $1M since the same quarter in the previous year.
Its net income has increased by 17.6% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 31.8% to $-2M since the same quarter in the previous year.
Based on the above factors, ReWalk Robotics Ltd gets an overall score of 4/5.